Archive of Past Articles and Xconomist Essays

Results for “”

Entry	Author	Date	Location
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades	Frank Vinluan	10/11/19	Indiana
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More	Frank Vinluan	10/11/19	San Francisco
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More	Alex Lash	10/11/19	National
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma	Frank Vinluan	10/10/19	Boston
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It?	Alex Lash	10/10/19	National
WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More	Jeff Bauter Engel	10/09/19	Wisconsin
Five Years After Y Combinator First Admits Biotechs, They’re Dug In	Bernadette Tansey	10/09/19	San Francisco
Pharma, Biotech VC Investments Continue Shift to Early Stage Deals	Sarah de Crescenzo	10/09/19	National
LabFellows Looks to Become “Operating System” For Life Sciences Cos.	Sarah de Crescenzo	10/08/19	San Diego
Catch Duchenne Patient Power, Phil Sharp & More Next Week at The Broad	Ben Fidler	10/08/19	Boston
With $65M, Cygnal Tunes In to Nerve Signals for Drug-Making Clues	Frank Vinluan	10/08/19	Boston
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels	Frank Vinluan	10/07/19	National
Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M	Ben Fidler	10/07/19	Boston
Precision IBD Rebrands as Prometheus and Strikes R&D Deal With Takeda	Sarah de Crescenzo	10/07/19	San Diego
Unpack Digital Health’s Progress & Pitfalls at X·CON on Oct. 22	Jeff Bauter Engel	10/07/19	Boston
Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates	Jeff Bauter Engel	10/04/19	Wisconsin
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More	Ben Fidler	10/04/19	National
After Brain Cancer Drug Fails, Tocagen to Cut More Than Half of Staff	Sarah de Crescenzo	10/03/19	San Diego
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street	Frank Vinluan	10/03/19	National
Icosavax Lands $51M to Bring Vaccine for Respiratory Virus to Clinic	Frank Vinluan	10/03/19	Seattle
Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto	Bernadette Tansey	10/02/19	San Francisco
Viscient Bio Proposes Organovo Merger to Tackle NASH and Go Beyond	Frank Vinluan	10/02/19	San Diego
Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?	David Holley	10/01/19	Texas
Molecular Assemblies Raises $12M to Advance Enzymatic DNA Synthesis	Sarah de Crescenzo	10/01/19	San Diego
Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO	Frank Vinluan	10/01/19	New York
We’re Beginning to Realize the Cloud’s Full Potential at the Edge	Ellen Rubin	10/01/19	Boston
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More	Ben Fidler	10/01/19	National
Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%	Frank Vinluan	09/30/19	Raleigh Durham
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs	Frank Vinluan	09/27/19	Boston
At Venture Summit, 3 Takeaways For Entrepreneurs From VC Phil Black	Sarah de Crescenzo	09/27/19	San Diego
Page 1 of 1952	next page »

Results for “”

Underwriters and Partners

Connect with Xconomy

Xconomy on Demand